Recent rise in STIs in the U.S. foreshadows the new monkeypox outbreak

NewsGuard 100/100 Score

The recent rise in sexually transmitted infections (STIs) in the United States foreshadowed the new monkeypox outbreak. The alarming STI numbers and a detailed description of monkeypox and its prevention and treatment are published in the peer-reviewed journal AIDS Patient Care and STDs.

The 2.4 million cases of STIs recorded in the U.S. in 2020 reflected a 45% increase in gonorrhea, a 52% increase in syphilis, and a 235% increase in congenital syphilis over the previous 5 years, according to author and Editor-in-Chief of AIDS Patient Care and STDs Jeffrey Laurence, MD, from Weill Cornell Medicine.

If these disturbing trends are to be reversed, then recommitment to public health initiatives along with the normalization of STI screening in all healthcare settings is required. The very recent outbreak of monkeypox worldwide, predominantly among men who have sex with men (MSM), is a clear example of failure to support such a commitment."

Jeffrey Laurence, MD, Weill Cornell Medicine

Dr. Laurence presents a primer on monkeypox and reviews the vaccines and therapeutics available to prevent and treat the disease. In addition to accelerating vaccine production, he discusses options for how we might intervene to prevent a monkeypox pandemic.

Journal reference:

Laurence, J., et al. (2022) The Recent Rise in Sexually Transmitted Infections in the United States Was a Harbinger of the New Monkeypox Pandemic. AIDS Patient Care and STDs.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
CRISPR could be used for faster monkeypox testing